Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
The goal of this observational study is to learn about the predict value of leukemia stem cell for acute myeloid leukemia patients with MLL-rearrangement. The main question it aims to answer is: • Could be leukemia stem cell used for relapse prediction in acute myeloid leukemia patients with MLL-rearrangement? Leukemia stem cell will be detected at the same time for participants who detected minimal residual disease using bone marrow as part of their regular medical care to answer the question.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 6
Maximum Age: 60
Healthy Volunteers: f
View:
• Acute myeloiud leukemia patients with MLL arrangement aging 6-60 years recieving chemoterapy or allo-geneic hematopoietic stem cell transplantation.
Locations
Other Locations
China
Peking University People's Hospital
RECRUITING
Beijing
Contact Information
Primary
Siqi Li, PhD
tina_li_1995@163.com
+86 18611944638
Time Frame
Start Date: 2025-06-01
Estimated Completion Date: 2026-04-07
Participants
Target number of participants: 210
Treatments
AML patients with MLL rearrangement
AML patients with MLL rearrangement who recieved chemnoptherapy or unerwent allo-SCT
Related Therapeutic Areas
Sponsors
Leads: Peking University People's Hospital